The FASEB Journal, Vol 7, 846-854, Copyright © 1993 by The Federation of American Societies for Experimental Biology

REVIEWS

Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression

PA Hamel, RA Phillips, M Muncaster and BL Gallie
Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Ontario, Canada.

Studies of retinoblastoma clearly identify mutation of the RB1 gene on chromosome 13 as the primary cause of this cancer. However, all retinoblastoma tumors have an abnormal karyotype (1, 2) indicating the presence of additional mutations and suggesting that mutation of both RB1 alleles is insufficient for development of retinoblastoma. In addition, analysis of RB1 expression and of RB1 mutations in different tumors leads to the following dilemma: while the RB1 gene product, p110RB1, is expressed in most dividing cells, germline mutations inactivating the function of p110RB1 predispose primarily to retinoblastoma and to a lesser extent to osteosarcoma, but do not predispose to cancer in general. However, many tumors contain somatic mutations that disrupt RB1 function. Thus, we are faced with the unusual situation in which germline mutations in the RB1 gene predispose to a very limited set of cancers, but somatic mutations in RB1 appear to contribute to malignancy in many tissues. We propose that the role of the RB1 gene is to maintain the cells in a stable, quiescent state required for terminal differentiation and that the effect of RB1 mutations in different tissues depends on the pattern of differentiation in that tissue. In tissues where differentiation follows a linear process from undifferentiated precursors to fully differentiated cells, loss of RB1 function during early stages of differentiation may lead to uncontrolled growth and the development of cancer. On the other hand, in cell renewal systems where cell number is usually maintained by a process of programmed cell death (PCD) or apoptosis, loss of RB1 function may lead to cell death.

This article has been cited by other articles:

				P. A. Sieving and F. S. Collins Genetic Ophthalmology and the Era of Clinical Care JAMA, February 21, 2007; 297(7): 733 - 736. [Full Text] [PDF]

				E. S. Tien, J. P. Gray, J. M. Peters, and J. P. Vanden Heuvel Comprehensive Gene Expression Analysis of Peroxisome Proliferator-treated Immortalized Hepatocytes: Identification of Peroxisome Proliferator-activated Receptor {alpha}-dependent Growth Regulatory Genes Cancer Res., September 15, 2003; 63(18): 5767 - 5780. [Abstract] [Full Text] [PDF]

				J. V. Jester, J. Huang, S. Fisher, J. Spiekerman, J. H. Chang, W. E. Wright, and J. W. Shay Myofibroblast Differentiation of Normal Human Keratocytes and hTERT, Extended-Life Human Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1850 - 1858. [Abstract] [Full Text] [PDF]

				M. Gadd, C. Pisc, J. Branda, V. Ionescu-Tiba, Z. Nikolic, C. Yang, T. Wang, G. M. Shackleford, R. D. Cardiff, and E. V. Schmidt Regulation of Cyclin D1 and p16INK4A Is Critical for Growth Arrest during Mammary Involution Cancer Res., December 1, 2001; 61(24): 8811 - 8819. [Abstract] [Full Text] [PDF]

				A. YU. NIKITIN, D. J. RILEY, and W.-H. LEE A Paradigm for Cancer Treatment Using the Retinoblastoma Gene in a Mouse Model Ann. N.Y. Acad. Sci., January 1, 1999; 886(1): 12 - 22. [Abstract] [Full Text] [PDF]

				N. S. B. Thomas, A. R. Pizzey, S. Tiwari, C. D. Williams, and J. Yang p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by alpha -Interferon J. Biol. Chem., September 11, 1998; 273(37): 23659 - 23667. [Abstract] [Full Text] [PDF]

				E. S. Knudsen, C. Buckmaster, T.-T. Chen, J. R. Feramisco, and J. Y.J. Wang Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression Genes & Dev., August 1, 1998; 12(15): 2278 - 2292. [Abstract] [Full Text]

				X. Tan, S. J. Martin, D. R. Green, and J. Y.J. Wang Degradation of Retinoblastoma Protein in Tumor Necrosis Factor- and CD95-induced Cell Death J. Biol. Chem., April 11, 1997; 272(15): 9613 - 9616. [Abstract] [Full Text] [PDF]

				C J Sherr and J M Roberts Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev., May 15, 1995; 9(10): 1149 - 1163. [PDF]

				P J Welch and J Y Wang Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes & Dev., January 1, 1995; 9(1): 31 - 46. [Abstract] [PDF]

				J. Schneider, W Gu, L Zhu, V Mahdavi, and B Nadal-Ginard Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells Science, June 3, 1994; 264(5164): 1467 - 1471. [Abstract] [PDF]

				K A Howes, N Ransom, D S Papermaster, J G Lasudry, D M Albert, and J J Windle Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes & Dev., June 1, 1994; 8(11): 1300 - 1310. [Abstract] [PDF]

				B. L. Gallie Retinoblastoma Gene Mutations in Human Cancer N. Engl. J. Med., March 17, 1994; 330(11): 786 - 787. [Full Text]